M7G-related LncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients with Oral Squamous Cell Carcinoma

Overview

Journal Front Genet

Date 2022 Dec 19

PMID 36531245

Authors

Xuefeng Wang

Wei Dong

Yanbo Zhang

Feng Huo

Affiliations

Soon will be listed here.

Abstract

Among head and neck cancers, oral squamous cell carcinoma (OSCC) is the most common malignant tumor. N-7-methylguanosine (m7G) and lncRNAs are both related to the development and progression of tumors. Therefore, this study aims to explore and establish the prognostic signal of OSCC based on m7G-related lncRNAs. In this study, RNA sequencing transcriptome data of OSCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Therefore, m7G-related lncRNAs were identified as differentially expressed in OSCC. Then, univariate Cox regression analysis and LASSO regression analysis were conducted to evaluate the prognostic significance of differentially expressed lncRNAs. Consequently, the abovementioned lncRNAs were assigned five OSCC patient risk scores, with high-risk and low-risk patients assigned to each group. Different signaling pathways were significantly enriched between the two groups as determined by set enrichment analysis (GSEA). Multivariate Cox regression analysis confirmed the factors used to construct the nomogram model. Then, the prognosis of the nomogram model was evaluated. Consequently, high-risk individuals had higher immune infiltration levels. According to the results of a study that evaluated the sensitivity of different risk subgroups to antitumour drugs, the high-risk group had a high sensitivity to doxorubicin. By performing real-time polymerase chain reaction (RT‒PCR), we verified the expression of these five m7G lncRNAs. Therefore, the model based on five m7G-related lncRNAs was able to predict the overall survival rates of OSCC patients and guide their treatment. It can also spur new ideas about how to prevent and treat OSCC.

Citing Articles

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression.

Mohd Faizal N, Shai S, Savaliya B, Karen-Ng L, Kumari R, Kumar R Biomedicines. 2025; 13(1).

PMID: 39857718 PMC: 11759772. DOI: 10.3390/biomedicines13010134.

Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort.

Camarena M, Theunissen P, Ruiz M, Ruiz-Orera J, Calvo-Serra B, Castelo R Sci Adv. 2024; 10(28):eadn3628.

PMID: 38985879 PMC: 11235171. DOI: 10.1126/sciadv.adn3628.

References

Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y . HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res. 2006; 66(18):9281-9. DOI: 10.1158/0008-5472.CAN-06-0488. View

Zhao F, Dong Z, Li Y, Liu S, Guo P, Zhang D . Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma. Front Oncol. 2022; 12:893186. PMC: 9329704. DOI: 10.3389/fonc.2022.893186. View

Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

Huang F, Xin C, Lei K, Bai H, Li J, Chen Q . Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma. Cell Oncol (Dordr). 2020; 43(5):763-777. DOI: 10.1007/s13402-020-00521-9. View

Sun J, Li L, Chen H, Gan L, Guo X, Sun J . Identification and Validation of an m7G-Related lncRNAs Signature for Prognostic Prediction and Immune Function Analysis in Endometrial Cancer. Genes (Basel). 2022; 13(8). PMC: 9330151. DOI: 10.3390/genes13081301. View

Ha S, Zhou H, Gautam M, Song Y, Wang C . Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma. Mol Genet Genomic Med. 2019; 7(7):e00783. PMC: 6625366. DOI: 10.1002/mgg3.783. View

Li S, Chen X, Liu X, Yu Y, Pan H, Haak R . Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncol. 2017; 73:1-9. DOI: 10.1016/j.oraloncology.2017.07.026. View

Chen H, Zhao J, Hu J, Xiao X, Shi W, Yao Y . Identification of Diagnostic Biomarkers, Immune Infiltration Characteristics, and Potential Compounds in Rheumatoid Arthritis. Biomed Res Int. 2022; 2022:1926661. PMC: 9007666. DOI: 10.1155/2022/1926661. View

Pandolfini L, Barbieri I, Bannister A, Hendrick A, Andrews B, Webster N . METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation. Mol Cell. 2019; 74(6):1278-1290.e9. PMC: 6591002. DOI: 10.1016/j.molcel.2019.03.040. View

10.

Nikitakis N, Pentenero M, Georgaki M, Poh C, Peterson D, Edwards P . Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125(6):650-669. DOI: 10.1016/j.oooo.2018.03.012. View

11.

Mishra R . Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncol. 2012; 48(7):578-84. DOI: 10.1016/j.oraloncology.2012.01.017. View

12.

Lu Z, Tang F, Li Z, Lai Y, Lu Z, Zhang J . Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer. Dis Markers. 2022; 2022:7931393. PMC: 8828356. DOI: 10.1155/2022/7931393. View

13.

Wang Y, Yao Y, Zhao J, Cai C, Hu J, Zhao Y . Development of an Autophagy-Related Gene Prognostic Model and Nomogram for Estimating Renal Clear Cell Carcinoma Survival. J Oncol. 2021; 2021:8810849. PMC: 7910047. DOI: 10.1155/2021/8810849. View

14.

Meng X, Lou Q, Yang W, Wang Y, Chen R, Wang L . The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. Cancer Commun (Lond). 2021; 41(10):981-1006. PMC: 8504146. DOI: 10.1002/cac2.12194. View

15.

Shimizu S, Hiratsuka H, Koike K, Tsuchihashi K, Sonoda T, Ogi K . Tumor-infiltrating CD8 T-cell density is an independent prognostic marker for oral squamous cell carcinoma. Cancer Med. 2019; 8(1):80-93. PMC: 6346233. DOI: 10.1002/cam4.1889. View

16.

Zhang S, Li J, Gao H, Tong Y, Li P, Wang Y . lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol. 2021; 9:656554. PMC: 8196240. DOI: 10.3389/fcell.2021.656554. View

17.

Almangush A, Leivo I, Makitie A . Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice. Acta Otolaryngol. 2020; 140(3):246-248. DOI: 10.1080/00016489.2020.1720284. View

18.

Begolli R, Sideris N, Giakountis A . LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential. Cancers (Basel). 2019; 11(10). PMC: 6826483. DOI: 10.3390/cancers11101524. View

19.

Weisse J, Rosemann J, Krauspe V, Kappler M, Eckert A, Haemmerle M . RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2020; 21(18). PMC: 7555251. DOI: 10.3390/ijms21186835. View

20.

Rong J, Wang H, Yao Y, Wu Z, Chen L, Jin C . Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma. Aging (Albany NY). 2022; 14(12):5233-5249. PMC: 9271298. DOI: 10.18632/aging.204151. View